Longtime activist investor Carl Icahn disclosed in a regulatory filing late Monday that he has trimmed his stake in Hertz Global Holdings.
Longtime activist investor Carl Icahn disclosed in a regulatory filing late Monday that he has trimmed his stake in Hertz Global Holdings, a position he's held since August 2014.
Shares of the Estero, Florida-based Hertz fell more than 6 percent in premarket trading Tuesday following news of the revised stake. The stock is up more than 46 percent this year alone, rebounding off a 38 percent loss in 2018.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Caesars reaches a deal with activist Carl Icahn to appoint 3 directors to its boardCaesars Entertainment said it had entered an agreement with billionaire activist Carl Icahn to appoint three directors to its board.
Read more »
Caesars bows to Icahn demands on board, sale still eyedU.S. casino operator Caesars Entertainment Corp has struck a deal with investor ...
Read more »
Here are the biggest analyst calls of the day: Delta, American Air, L Brands, Hertz, Party City & MichaelsHere's the calls of the day that we're watching
Read more »
Caesars reaches a deal with activist Carl Icahn to appoint 3 directors to its boardCaesars Entertainment said it had entered an agreement with billionaire activist Carl Icahn to appoint three directors to its board.
Read more »
Global stock market resurgence to be short-lived, 2019 outlook cut: Reuters pollGlobal stock markets in 2019 will at best only recoup losses from the deep sell-...
Read more »
Activist investor Starboard Value says it will oppose Bristol-Myers' deal for CelgeneThe activist investor said Thursday that it intends to use its stake in Bristol-Myers Squibb to oppose its acquisition of Celgene.
Read more »
Activist investor Starboard Value says it will oppose Bristol-Myers' $74 billion deal for CelgeneActivist investor Starboard Value said that it intends to use its stake in Bristol-Myers Squibb to oppose the drug-maker’s acquisition of Celgene.
Read more »
Stocks jump on signs U.S., China close to trade dealAsian shares gained on Monday on reports the United States and China were close ...
Read more »